Minoxidil: Clinical Trials

8 trials of Minoxidil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 3, Unknown 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Minoxidil: new trials by email Literature Review of Minoxidil trials Research Report on Minoxidil

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical Methotrexate vs Minoxidil for Localized Alopecia Areata
Methotrexate 1% Topical Gel, Minoxidil 5% Topical Spray - Alopecia Areata
Phase 4Not yet recruitingJinnah Postgraduate Medical Centre2682026-03-152026-03-10
Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia
Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil - Androgenetic Alopecia
Phase 4UnknownUniversitas Indonesia362023-06-012023-09-21
Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia
Cetirizine, Minoxidil - Androgenetic Alopecia
Phase 4UnknownAssiut University602020-06-012020-03-04
N-Acetyl-Cysteine for Treatment of AGA in Men
Minoxidil 5% topically and oral NAC 600 mg - Androgenetic Alopecia
Phase 4CompletedKafrelsheikh University1002018-12-012025-08-27
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Topical steroid class I-II, Triamcinolone Acetonide, Doxycyline - Central Centrifugal Cicatricial Alopecia (CCCA)
Phase 4RecruitingWake Forest University Health Sciences2502018-04-302026-03-31
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
5% Minoxidil, 200mg Spironolactone, 5mg Finasteride - Female Androgenetic Alopecia
Phase 4WithdrawnUniversity of Florida2016-08-012016-09-02
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Triamcinolone Acetonide, Minoxidil 5 % Topical Spray, clobetasol propionate - Alopecia Areata
Phase 4CompletedCairo University402016-03-012018-05-24
Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss
Topical minoxidil 5% in 90% ethanol and 5% propylene glycol, Topical minoxidil 5% in pure ethanol alone, Placebo (Ethanol) - Female Pattern Hair Loss
Phase 4CompletedSohag University602015-05-302019-09-26

Conditions studied

Alopecia (5)  ·  Alopecia Areata (2)

Sponsors

Assiut University (1)  ·  Cairo University (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Kafrelsheikh University (1)  ·  Sohag University (1)  ·  Universitas Indonesia (1)  ·  University of Florida (1)  ·  Wake Forest University Health Sciences (1)

Countries

Egypt (2)  ·  United States (2)  ·  Indonesia (1)

Top investigators

Adhika A Lestari, MD (1)  ·  Amy J McMichael, MD (1)  ·  Christina L. Mitchell, M.D. (1)  ·  Heba M Mashaly, MD (1)  ·  Mahira H El Sayed, Professor (1)  ·  Mohammed Abu El-Hamd, MD (1)  ·  Mona MI ElKalioby, MD (1)  ·  Nermine H El-Eishi, MD (1)  ·  Olfat G Shaker, MD (1)  ·  Rania M Abdel-Hay, MD (1)  ·  Sahar Abd-ElMoez (1)  ·  Solwan I El-Samanoudy, MD (1)

Results publications

PMID 25315746, PMID 30501016, PMID 31823902, PMID 32231700, PMID 32346854, PMID 35318791, PMID 35492401, PMID 35796224, PMID 36257912